Neurogene Inc (NGNE)

EBITDA Growth

-58.49%

Quarterly · Period ending:

NGNE logo

NGNE EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-58.49%
NGNE Quarterly EBITDA YoY % (-45.26% → -58.49%)
High-resolution chart · PNG

NGNE ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Neurogene Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-58.4855%
-37.4583%
-27.963%
-3.9625%
-20.2422%
-35.9784%
-682.2651%
-41.1932%
-60.1504%
-40.6362%
125.1055%
-14.944%
26.2926%
22.1035%
11.929%
19.4964%
-2.6256%
-1.7454%
-19.3334%
-721.5708%
-62.1498%
-70.4403%
-53.3359%
96.9424%
-899,500%
-283.6504%
-62.6869%
-294.3974%
-100.0343%
84.9005%
69.9766%
-26.705%
121.1972%
-75.8418%
-44.6589%
-45.2615%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.